Browse > Article
http://dx.doi.org/10.3746/jfn.2002.7.2.168

Ability of Lactobacillus GR-1 and RC-14 to Stimulate Host Defences and Reduce Gut Translocation and Infectivity of Salmonella typhimurium  

Reid, Gregor (Lawson Health Research Institute, and Departments of Microbiology and Immunology, and Surgery, The University of Western Ontario, London, Ontario Canada)
Charbonneau, Duane (Procter & Gamble Healthcare Research Centre, Mason, Ohio)
Erb, Julie (Procter & Gamble Healthcare Research Centre, Mason, Ohio, USA)
Poehner, Russ (Procter & Gamble Healthcare Research Centre, Mason, Ohio, USA)
Gonzalez, Silvia (Centro de Referencias para Lactobacilos (CERELA), Tucuman, Agrentina)
Gardiner, Gillian (Lawson Health Research Institute)
Bruce, Andrew W. (Lawson Health Research Institute)
Publication Information
Preventive Nutrition and Food Science / v.7, no.2, 2002 , pp. 168-173 More about this Journal
Abstract
Gastrointestinal infections kill over two million people each year, and pathogen contamination of livestock causes many cases of food poisoning. Two candidate intestinal probiotic strains, L. rhamnosus GR-1 and L. fermentum RC-14 were found to inhibit the growth of Salmonella typhi, Shigella dysenteriae, E. coli O157:H7, Listeria monocytogenes, L. innocua, Enterococcus faecalis, and Bacteroides fragilis. In a series of mouse experiments, L. rhamosus GR-1 and L rhamnosus GG protected against S. typhimurium infection and translocation to the liver and spleen, reduced mortality and induced intestinal phagocytic and immunoglobulin responses. In a second series of experiments, the combination of L. rhamnosus GR-1 and L. fermentum RC-14 was superior to L. rhamnosus GG and placebo in protecting the mice from the lethal effect of salmonella. In summary, the use of combinations of probiotic lactobacilli as dietary supplements or foods could be considered for people at high risk of salmonella intestinal infection. Given the post-infection complications that can arise, such natural methods warrant further exploration especially given the increasing problem of antibiotic resistance and the lack of alternative measures available to many developing countries.
Keywords
lactobacilli; probiotics; intestine; immune response; pathogen inhibition;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Ribeiro H Jr. 2000. Diarrheal disease in a developing nation. Am J Gastroenterol 95: S14-15   DOI   ScienceOn
2 Villar RG, Macek MD, Simons S, Hayes PS, Goldoft MJ, Lewis JH, Rowan LL, Hursh D, Patnode M, Mead PS. 1999. Investigation of multidrug-resistant Salmonella serotype typhimurium DT104 infections linked to raw-milk cheese in Washington State. JAMA 281: 1811-1816   DOI   ScienceOn
3 Guerrant RL, Lima AA, Barboza M, Young S, Silva T, Barrett L, Bao Y, Fox J, Moore S. 1999. Mechanisms and impact of enteric infections. Adv Exp Med Biol 473: 103-112   DOI
4 FAO/WHO. 2001. Evaluation of health and nutritional properties of powder milk and live lactic acid bacteria. Food and Agriculture Organization of the United Nations and World Health Organization Expert Consultation Report, http://www.fao.org/es/ESN/Probio/probio.htm
5 De Roos NM, Katan MB. 2000. Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: a review of papers published between 1988 and 1998. Am J Clin Nutr 71: 405-411
6 Reid G, Bruce AW, Fraser N, Heinemann C, Owen J, Henning B. 2001. Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol 30: 49-52   DOI   ScienceOn
7 Gardiner G, Heinemann C, Madrenas J, Bruce AW, Beuerman D, Baroja L, Reid G. 2002. Oral administration of the probiotic combination Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 for human intestinal applications. Int Dairy J 12: 191-196   DOI   ScienceOn
8 Rabsch W, Tschape H, Baumler AJ. 2001. Salmonella typhimurium strains resistant to multiple antibiotics have emerged and spread within populations of food animals. Non-typhoidal salmonellosis: emerging problems. Microbes Infect 3: 237-247   DOI   ScienceOn
9 Gardiner G, Heinemann C, Beuerman D, Bruce AW, Reid G. 2002. Persistence of Lactobacillus fermentum RC-14 and L. rhamnosus GR-1, but not L. rhamnosus GG in the human vagina as demonstrated by randomly amplified polymorphic DNA (RAPD). Clin Diag Lab Immunol 9: 92-96
10 McGroarty JA, Reid G. 1988. Detection of a lactobacillus substance which inhibits Escherichia coli. Can J Microbiol 34: 974-978   DOI   ScienceOn
11 Heinemann C, Van Hylckama Vlieg JET, Janssen DB, Busscher HJ, van der Mei HC, Reid G. 2000. Purification and characterization of a surface-binding protein from Lactobacillus fermentum RC-14 inhibiting Enterococcus faecalis 1131 adhesion. FEMS Microbiol Letts 190: 177-180   DOI   ScienceOn
12 Chan RCY, Reid G, Irvin RT, Bruce AW, Costerton JW. 1985. Competitive exclusion of uropathogens from uroepithelial cells by Lactobacillus whole cells and cell wall fragments. Infect Immun 47: 84-89
13 Oberhelman RA, Gilman RH, Sheen P, Taylor DN, Black RE, Cabrera L, Lescano AG, Meza R, Madico G. 1999. A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children. J Pediatr 134: 1-2   DOI   ScienceOn
14 Mack DR, Michail S, Wei S, McDougall L, Hollingsworth MA. 1999. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 276: G941-950
15 Saxelin M. 1997. Lactobacillus GG-A human probiotic strain with thorough clinical documentation. Food Rev Int 13: 293-313   DOI   ScienceOn
16 Guandalini S, Pensabene L, Zikri MA. 2000. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J Pediatr Gastroenterol Nutr 30: 54-60   DOI   ScienceOn
17 Yasui H, Shida K, Matsuzaki T, Yokokura T. 1999 Immunomodulatory function of lactic acid bacteria. Antonie van Leeuwenhoek 76: 383-389   DOI   ScienceOn
18 Reid G, Bruce AW. 2001. Selection of Lactobacillus strains for urogenital probiotic applications. J Infect Dis 183: S77-80   DOI   ScienceOn
19 Perdigon G, Rachid M, De Budeguer MV, Valdez JC. 1994. Effect of yogurt feeding on the small and large intestine associated lymphoid cells in mice. J Dairy Res 61: 553-562   DOI   ScienceOn
20 Perdigon G, Alvarez S, Pesce de Ruiz Holgado A. 1991. Immunoadjuvant activity of oral Lactobacillus casei: influence of dose on the secretory immune response and protective capacity in intestinal infections. J Dairy Res 58: 485- 496   DOI   ScienceOn
21 McCracken VJ, Gaskins HR. 1999. Probiotics and the immune system. In Probiotics: a clinical review. Horizon Scientific Press, Wymondham, UK. p 85-111
22 Henriksson A, Conway PL. 2001. Isolation of human faecal bifidobacteria which reduce signs of Salmonella infection when orogastrically dosed to mice. J Appl Microbiol 90: 223-228   DOI   ScienceOn
23 Raza S, Graham SM, Allen SJ, Sultana S, Cuevas L, Hart CA. 1995. Lactobacillus GG promotes recovery from acute non bloody diarrhea in Pakistan. Ped Infect Dis J 14: 107- 111   DOI
24 Shanahan F. 2000. Immunology. Therapeutic manipulation of gut flora. Science 289: 1311-1312   DOI   ScienceOn
25 McKendrick MW. 1996. Post Salmonella irritable bowel syndrome-5 year review. J Infect 32: 170-171
26 Thomson GT, Chiu B, De Rubeis D, Falk J, Inman RD. 1992. Immunoepidemiology of post-Salmonella reactive arthritis in a cohort of women. Clin Immunol Immunopathol 64: 227-232   DOI   ScienceOn